Name: Latest research reports of Rossari Biotech Ltd. authored by KRChoksey and published by - Trendlyne research reports.
Item: Rossari Biotech Ltd.
Rating: 5
Author: KRChoksey

Rossari Biotech Ltd.

NSE: ROSSARI | BSE: 543213 | ISIN: INE02A801020 | Industry: Specialty Chemicals
| Mid-range Performer

627.5500 14.35 (2.34%)

NSE Mar 21, 2025 15:31 PM

35.48% Fall from 52W High

Volume: 98,153

Rossari Biotech Ltd.

25 Jan 2024

627.55

2.34%

Strong revenue growth with stable profitability

Buy: Rossari Biotech Ltd.

Recommendation Target

KRChoksey

For Q3FY24, Rossari Biotech's revenue was INR 4,638 Mn which grew by 19.1% YoY but declined by 4.1% QoQ. This growth was driven by strong growth in HPPC segment, which posted solid double-digit growth of 31.1% YoY but declined 3.2% QoQ to reach revenue of INR 3,554 Mn.

Rossari Biotech Ltd. has lost -20.89% in the last 3 Months